Bulletin Board Archive

Bulletin Board

April 29, 2024

Site Icon for Allergy Asthma Network. Dark Dusty Blue circle with stylized yellow suns rays on top

Trusted Messengers is Back!

Our Trusted Messengers community outreach was back in action March 2 at the Black Health Matters Winter 2024 Health Summit & Expo in Atlanta. Leandra Tonweber, PA-C, and Catherine Blackwell, RN, connected with the Atlanta community, surveyed attendees, and gave away free resources. People with asthma were invited to enroll in our free 6-week virtual asthma coaching program.

Site Icon for Allergy Asthma Network. Dark Dusty Blue circle with stylized yellow suns rays on top

Atopic Dermatitis Abstracts

Chief Research Officer De De Gardner served as a co-author for two atopic dermatitis studies that examined the benefits and risks of topical treatments and systemic treatments, including topical corticosteroids, JAK inhibitors and biologics. The first-of-its-kind study can be used to inform doctor-patient discussions and for future research.

Site Icon for Allergy Asthma Network. Dark Dusty Blue circle with stylized yellow suns rays on top

AADCH Speakers Announced

Our 27th annual advocacy day on Capitol Hill in Washington, DC is Wednesday, May 8. We are excited to welcome U.S. Reps. David Valadao (CA) and Debbie Dingell (MI), our Congressional Asthma & Allergy Caucus co-chairs, as scheduled speakers at AADCH. There’s still time to register for AADCH – advocate for key healthcare legislation.

Bulletin Board

March 26, 2024

AAN SiteIcon3 150x150 1

AAN Receives NIH Sub-Award

Allergy & Asthma Network and Blue Marble Health are collaborating on a new virtual asthma coaching platform, with funding support from the National Institutes of Health (NIH). AAN will use Blue Marble’s BREATHE virtual platform for asthma self-management education, with a focus on under-resourced communities.

AAN SiteIcon3 150x150 1

Affordable Asthma Inhalers

CEO Lynda Mitchell recently spoke with The Lancet Respiratory Medicine about the U.S. Senate investigation into the cost of asthma inhalers. Ensuring access and affordability of medications is one of Allergy & Asthma Network’s key advocacy initiatives. “We support price caps on inhalers,” Lynda says, adding that AAN will monitor if there’s an impact on availability.

AAN SiteIcon3 150x150 1

Advancing Disparities Research

Allergy & Asthma Network partnered with MITRE on the new Asthma Equity Explorer, a free web-based platform that disseminates data on asthma prevalence and disparities in the United States. Researchers and health professionals can examine how social determinants of health impact asthma outcomes on national, state and local levels.

Bulletin Board

February 27, 2024

Site Icon for Allergy Asthma Network. Dark Dusty Blue circle with stylized yellow suns rays on top

Severe Asthma Study Insight

Medical Advisor Vickram Tejwani, MD, and Asthma Coach Leandra Tonweber, PA-C, AE-C, offered their perspective on an eosinophilic asthma study examining the reduced use of inhaled corticosteroids (ICS) among people taking the biologic benralizumab. Dr. Tejwani told Healio.com the findings were “significant” and offer data to support reducing ICS in people who respond well to biologic therapy.

Site Icon for Allergy Asthma Network. Dark Dusty Blue circle with stylized yellow suns rays on top

Support for New EPIPEN Act

Allergy & Asthma Network is among patient advocacy groups supporting the EPIPEN Act introduced in Congress by Rep. Maxwell Frost (FL). The legislation would put a price cap on epinephrine auto-injectors. “High out-of-pocket costs for these potentially life-saving medications put Americans with severe allergies at risk for poor health outcomes and deepen health inequities,” CEO Lynda Mitchell says.

Site Icon for Allergy Asthma Network. Dark Dusty Blue circle with stylized yellow suns rays on top

Newly Updated Poster for 2024

Our popular Respiratory Treatments poster is newly updated for 2024 – and available now! It contains the newest asthma and COPD medications, including AirSupra®. The poster offers a comparison of the various treatment options, helps doctors and patients easily identify inhalers, and is a great reference for patient education. It’s available in both English and Spanish.

Bulletin Board

January 23, 2024

AAN SiteIcon3 150x150 1

Shared Decision-Making Study

Allergy & Asthma Network conducted a survey of allergists and patients last year to gauge awareness of Shared Decision-Making (SDM). The survey also aimed to find out what barriers impact SDM use in clinical settings. Among the survey findings: most allergists and patients understand SDM, but did not often use available tools and may need guidance on how to use them.

AAN SiteIcon3 150x150 1

Trusted Messengers Impact

Allergy & Asthma Network is proud to share the latest results of its signature health equity initiative, Trusted Messengers. Trusted Messengers uses innovative health technology to achieve health equity through its Virtual Asthma Coaching Program. The coaching program has demonstrated improvements in asthma control and quality of life that is sustained at 7-month and 13-month follow-ups.

AAN SiteIcon3 150x150 1

TikTok and Epi Poster

Tori Martel, our Digital Projects and Social Media Community Manager, presented a poster on epinephrine auto-injector needle fears in TikTik videos during the American College of Allergy, Asthma & Immunology Annual Scientific Meeting Nov. 9-13. The popularity of the videos – they totaled 5+ million “likes” – represents an opportunity to address patient education on epinephrine.